Cite
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment.
MLA
Zhang, Rui, et al. “Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinolines Derivatives as Novel, Selective PDE4 Inhibitors for Antipsoriasis Treatment.” European Journal of Medicinal Chemistry, vol. 211, Feb. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2020.113004.
APA
Zhang, R., Li, H., Zhang, X., Li, J., Su, H., Lu, Q., Dong, G., Dou, H., Fan, C., Gu, Z., Mu, Q., Tang, W., Xu, Y., & Liu, H. (2021). Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment. European Journal of Medicinal Chemistry, 211, N.PAG. https://doi.org/10.1016/j.ejmech.2020.113004
Chicago
Zhang, Rui, Heng Li, Xianglei Zhang, Jian Li, Haixia Su, Qiukai Lu, Guangyu Dong, et al. 2021. “Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinolines Derivatives as Novel, Selective PDE4 Inhibitors for Antipsoriasis Treatment.” European Journal of Medicinal Chemistry 211 (February): N.PAG. doi:10.1016/j.ejmech.2020.113004.